Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Portable Test Detects Zika and Hepatitis C RNA from Whole Blood

By LabMedica International staff writers
Posted on 11 Nov 2026

Timely detection of Zika virus and hepatitis C is essential, but conventional testing often relies on centralized laboratories and complex sample processing. More...

In regions with limited medical infrastructure, specimen transport and purification requirements can delay diagnosis, while RNA degradation may compromise molecular detection. Researchers have now developed a portable protocol that enables direct detection of viral RNA from whole blood without conventional laboratory equipment.

Researchers at the Grainger College of Engineering at the University of Illinois Urbana-Champaign developed a point-of-care protocol for detecting Zika virus and hepatitis C viral RNA directly from whole blood. The method uses heat to dry blood samples before amplifying the preserved viral RNA and detecting it through fluorescence. Requiring only a portable heater and handheld fluorescence reader, the workflow can be completed on site within hours.

Unlike conventional molecular testing, which relies on purification to remove substances in whole blood that interfere with detection, the new approach eliminates the need for centrifuges and specialized extraction equipment. Rather than miniaturizing existing laboratory procedures, researchers adapted a biphasic reaction strategy to minimize sample loss during processing while maintaining sensitivity at low viral RNA concentrations.

The team also addressed RNA instability in whole blood, where naturally occurring enzymes can rapidly degrade viral RNA, particularly during heat-based processing. The protocol incorporates measures to protect RNA from degradation throughout sample preparation, amplification, and fluorescence-based detection.elerate degradation. The protocol incorporates measures intended to prevent degradation during processing, amplification, and fluorescence-based detection.

The work was described in Science Advances under the title “Amplification of RNA for identification of Zika and HCV in whole blood.” It involved research groups in bioengineering and electrical and computer engineering at Illinois Grainger Engineering. The pocket-sized fluorescence device used to read test results was developed within the electrical and computer engineering research group and is part of a system requiring low amounts of power for point-of-care deployment.

“We needed to come up with a way to prevent degradation at each step of the procedure. In trying so many different combinations, we were able to deduce mechanistic explanations for what works and what doesn't. I think this will lead to a huge leap forward in how we detect other diseases caused by RNA viruses such as Ebola and Lassa fever,” said Jongwon Lim, a former postdoctoral researcher with Illinois Grainger Engineering and current postdoctoral researcher with the Broad Institute of MIT and Harvard.

Related Links
The University of Illinois Urbana-Champaign


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Gastrointestinal Panel
Xpert® GI Panel
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: These new ANC reference ranges can help clinicians more accurately interpret neutrophil counts, reduce unnecessary testing and treatment interruptions, and help support more equitable care. (Photo courtesy of the American Society of Hematology)

New Reference Ranges Clarify Normal Neutrophil Counts in Duffy-Null Patients

Duffy-null status is a common genetic trait associated with naturally lower circulating white blood cell counts. It affects about 10% of the U.S. population and more than 66% of people with African or... Read more

Immunology

view channel
Image: Melioidosis is a serious, sometimes fatal infection caused by Burkholderia pseudomallei, a bacterium found in tropical and subtropical soil and surface water. (Image Credit: Adobe Stock)

Antibody Testing Informs Melioidosis Diagnosis and Surveillance in Emerging Regions

Melioidosis is a serious and sometimes fatal infection caused by the soil- and water-dwelling bacterium Burkholderia pseudomallei. People and animals can contract the disease through exposure to contaminated... Read more

Microbiology

view channel
Image: VITEK PRO combines microbial identification and antimicrobial susceptibility testing on a single platform to support routine microbiology workflows and antibiotic selection. (Photo courtesy of bioMérieux)

Automated Microbial Identification and Susceptibility System Gains FDA Clearance

Antimicrobial resistance (AMR) is a leading global public health threat, causing an estimated 1.27 million deaths annually. The growing challenge of diagnosing and treating resistant infections highlights... Read more

Pathology

view channel
AI: Artificial intelligence; CNN: Convolutional neural networks; ResNet: Residual neural network. (Xing-hua Gao from The First Hospital of China Medical University, China Image Source Link: https://www.ovid.com/jnls/cmj/fulltext/10.1097/cm9.0000000000004154~deep-learning-based-computational-pathology-technologies)

Review Highlights Progress and Validation Needs for AI in Digital Pathology

Pathology remains the gold standard for disease diagnosis, but clinical laboratories face growing demands for faster, more reproducible diagnostic and prognostic workflows. Digital pathology based on whole-slide... Read more

Industry

view channel
Image: Siemens Healthineers has begun carving out its in vitro diagnostics business as a standalone company named Olyrian Diagnostics (Photo courtesy of Siemens Healthineers)

Siemens Healthineers Begins Transition Toward Standalone Olyrian Diagnostics Business

Siemens Healthineers has begun carving out its in vitro diagnostics business, which will operate as Olyrian Diagnostics. The new name will be introduced in stages as the business prepares to become a standalone... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.